" ...they have found the only treatment in the world that stops PD in it's tracks.."
you might wanna retract that, id2t
dont get yourself into hot water over unsubstantiated, if it was substantiated we wouldnt need a full trial
- Forums
- ASX - By Stock
- 1AI
- Ann: NTCELL Parkinsons trial 2 year data analysis shows success
Ann: NTCELL Parkinsons trial 2 year data analysis shows success, page-27
Featured News
Add 1AI (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.81M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $13.90K | 1.986M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 3764983 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 41489 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 3764983 | 0.006 |
11 | 3916885 | 0.005 |
6 | 4095009 | 0.004 |
3 | 3800000 | 0.003 |
2 | 1050000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 41489 | 1 |
0.008 | 1901847 | 6 |
0.009 | 3869315 | 9 |
0.010 | 2413365 | 3 |
0.011 | 836153 | 2 |
Last trade - 10.57am 15/11/2024 (20 minute delay) ? |
Featured News
1AI (ASX) Chart |
The Watchlist
BTH
BIGTINCAN HOLDINGS LIMITED
David Keane, Co-Founder & CEO
David Keane
Co-Founder & CEO
Previous Video
Next Video
SPONSORED BY The Market Online